TY - JOUR
T1 - Influence of sample centrifugation on plasma platelet count and activated partial thromboplastin time using patient samples
AU - Jesting, Amalie
AU - Jacobsen, Katja Kemp
AU - De Cock, Aaron
AU - De Preester, Henri
AU - Jensen, Kathrine Overgaard Foss
AU - Frank Jørgensen, Søren
N1 - Publisher Copyright:
© 2020 The Canadian Society of Clinical Chemists
PY - 2020/9
Y1 - 2020/9
N2 - Background: Diagnostic coagulation testing is vulnerable to factors of the pre-analytical phase such as sample centrifugation. Despite this, centrifugation conditions differ widely among European laboratories. Here we use samples from patients referred for Activated partial thromboplastin time (APTT) testing to investigate if different centrifugation conditions result in platelet-poor plasma (PPP) (plasma platelet count < 10 × 10
9/L) and how the variation in centrifugation conditions affect APTT measurements. Methods: Centrifugation of 2000g (10 min) were compared with 3000g (10 min) using samples from patients referred for APTT testing (n = 70). Plasma platelet count and APTT were measured to investigate the influence of the centrifugation conditions. Differences were evaluated using Bland Altman Plots and Student's t-test. Results: Centrifugation at 3000g for 10 min produced PPP for more of the samples (64%) than centrifugation at 2000g (6%) (p < 0.001). No statistically significant difference for APTT (p = 0.265) was found for samples with APTT < 37 s while samples with prolonged APTT (>37 s) showed a statistically significant difference (p = 0.025). The Bland Altman plot did not reveal a clinically significant difference (mean difference 0.30 s/0.68%) when compared to a maximum acceptable bias of 10%. Conclusion: None of the centrifugation conditions used in this study adequately secured PPP for all samples. Despite a statistically significant difference between samples with prolonged APTT, no clinically significant difference was observed when comparing all APTT measurements.
AB - Background: Diagnostic coagulation testing is vulnerable to factors of the pre-analytical phase such as sample centrifugation. Despite this, centrifugation conditions differ widely among European laboratories. Here we use samples from patients referred for Activated partial thromboplastin time (APTT) testing to investigate if different centrifugation conditions result in platelet-poor plasma (PPP) (plasma platelet count < 10 × 10
9/L) and how the variation in centrifugation conditions affect APTT measurements. Methods: Centrifugation of 2000g (10 min) were compared with 3000g (10 min) using samples from patients referred for APTT testing (n = 70). Plasma platelet count and APTT were measured to investigate the influence of the centrifugation conditions. Differences were evaluated using Bland Altman Plots and Student's t-test. Results: Centrifugation at 3000g for 10 min produced PPP for more of the samples (64%) than centrifugation at 2000g (6%) (p < 0.001). No statistically significant difference for APTT (p = 0.265) was found for samples with APTT < 37 s while samples with prolonged APTT (>37 s) showed a statistically significant difference (p = 0.025). The Bland Altman plot did not reveal a clinically significant difference (mean difference 0.30 s/0.68%) when compared to a maximum acceptable bias of 10%. Conclusion: None of the centrifugation conditions used in this study adequately secured PPP for all samples. Despite a statistically significant difference between samples with prolonged APTT, no clinically significant difference was observed when comparing all APTT measurements.
KW - disease, health science and nursing
KW - clinical assessment methods, lab technology and radiography
KW - diagnostic coagulation testing
UR - http://www.scopus.com/inward/record.url?scp=85085512411&partnerID=8YFLogxK
U2 - 10.1016/j.clinbiochem.2020.05.006
DO - 10.1016/j.clinbiochem.2020.05.006
M3 - Journal article
C2 - 32446848
SN - 0009-9120
VL - 83
SP - 74
EP - 77
JO - Clinical Biochemistry
JF - Clinical Biochemistry
IS - sept.
ER -